Tilda
Tilda operates a high-performance clinical trial site network specializing in phases 2 to 4, with over 250 studies conducted and more than 2,500 patients across 4 locations. The company excels in therapeutic areas such as Alzheimer’s and infectious diseases, utilizing advanced technology and workflow automation to ensure high-quality patient care and efficient trial execution.
Company Overview
Tilda is a high-performance clinical trial site network that operates across four locations. Headquartered at 14642 Newport Ave, Suite 350, Tustin, CA 92780, the company has dedicated research sites in Tustin, CA; Redlands, CA; and Birmingham, AL. Specializing in phases II-IV of clinical trials, Tilda is a trusted partner for sponsors and CROs due to its technology-led site network that focuses on delivering high-quality studies and first-rate patient care. The company has conducted over 250 studies and engages over 2,500 patients.
Clinical Trials and Studies
Tilda has successfully conducted over 250 studies across various therapeutic areas. The company's site network specializes in clinical trials from phases II to IV. Notable achievements include being ranked in the top 5% for the number of screens per week in an Alzheimer’s study and achieving #1 top-enroller status in an infectious disease study. Additionally, Tilda has demonstrated excellence in trial execution, achieving 45% of study enrollment and reducing query days-outstanding by 80% during an infectious disease study. Currently, the company is recruiting for trials in hypertension, cardiovascular disease, major depressive disorder, and Alzheimer’s disease.
Technological Innovations and Methodologies
Tilda leverages cutting-edge workflow automation software to streamline clinical trial processes. This technology-centric approach has enabled the company to achieve significant milestones, including generating 50% fewer queries during studies and achieving an average query close-out time of 3 days compared to the study-wide average of 25 days. By centralizing key functions such as query management and incorporating real-time tracing and automation technologies, Tilda has resolved 75% of queries promptly, contributing to the high quality and reliability of clinical data.
Therapeutic Areas
Tilda specializes in 9 therapeutic areas, with a particular focus on indications that benefit from dedicated research centers. Currently, the company is involved in clinical trials for hypertension, cardiovascular disease, major depressive disorder, and Alzheimer’s disease, among others. Tilda’s expertise in these areas, combined with its technology-driven approach, allows for efficient and effective trial execution, providing participants with access to new and advanced investigational treatment options.
Patient Care and Community Engagement
Tilda is committed to providing excellent patient care and supports its Diversity, Equity, and Inclusion (DEI) goals through community-centric recruitment strategies. The company offers study-related medication at no cost to participants and provides compensation for time and travel in most studies. By developing streamlined study processes and a robust site operating model, Tilda ensures high-confidence clinical data and exceptional patient care. This patient-centric approach has made Tilda a trusted partner for both study participants and research sponsors.